AQB
Closed
Aquabounty Technologies Inc
0.741
+0.001 (+0.14%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 0.74
Day's Range: 0.73 - 0.7589
Send
sign up or login to leave a comment!
When Written:
0.5948
AquaBounty Technologies Inc. is a biotechnology company that specializes in the development and commercialization of genetically modified (GM) fish. The company was founded in 1991 and is headquartered in Maynard, Massachusetts, USA.
AquaBounty's flagship product is the AquAdvantage salmon, a GM Atlantic salmon that grows faster than conventional salmon. The company has developed a proprietary technology called "AquAdvantage" that allows it to produce fish faster and more efficiently than traditional aquaculture methods.
The AquAdvantage salmon was approved for commercial production by the US Food and Drug Administration (FDA) in 2015, making it the first GM animal approved for human consumption. The salmon is currently being grown in a facility in Indiana and is expected to be available for sale in the US in the near future.
AquaBounty is also developing other GM fish species, including trout and tilapia, using its AquAdvantage technology. The company's goal is to create more sustainable and efficient ways of producing fish to meet the growing demand for seafood worldwide.
AquaBounty is publicly traded on the NASDAQ stock exchange under the ticker symbol "AQB".
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
AquaBounty's flagship product is the AquAdvantage salmon, a GM Atlantic salmon that grows faster than conventional salmon. The company has developed a proprietary technology called "AquAdvantage" that allows it to produce fish faster and more efficiently than traditional aquaculture methods.
The AquAdvantage salmon was approved for commercial production by the US Food and Drug Administration (FDA) in 2015, making it the first GM animal approved for human consumption. The salmon is currently being grown in a facility in Indiana and is expected to be available for sale in the US in the near future.
AquaBounty is also developing other GM fish species, including trout and tilapia, using its AquAdvantage technology. The company's goal is to create more sustainable and efficient ways of producing fish to meet the growing demand for seafood worldwide.
AquaBounty is publicly traded on the NASDAQ stock exchange under the ticker symbol "AQB".
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!